SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001640334-21-003300
Filing Date
2021-12-28
Accepted
2021-12-28 16:06:17
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 lxrp_424b3.htm 424B3 1296482
2 lxrp_s1aimg10.jpg GRAPHIC 22529
3 lxrp_s1aimg11.jpg GRAPHIC 4782
4 lxrp_s1aimg7.jpg GRAPHIC 6208
5 lxrp_s1aimg8.jpg GRAPHIC 8493
6 lxrp_s1aimg9.jpg GRAPHIC 4782
  Complete submission text file 0001640334-21-003300.txt   1362676
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B3 | Act: 33 | File No.: 333-250326 | Film No.: 211525038
SIC: 2834 Pharmaceutical Preparations